American Riviera
You are here:  Home  >  Biotech  >  Current Article

Capsida’s new CEO hopes success is in the genes

By   /   Friday, January 7th, 2022  /   Comments Off on Capsida’s new CEO hopes success is in the genes

    Print       Email
A Capsida scientist at work in the company’s laboratory in Thousand Oaks. (courtesy photo) Many companies will be facing familiar and tough challenges in 2022 as year three of the COVID-19 pandemic begins. Capsida Biotherapeutics, a venture-backed biotechnology startup in Thousand Oaks, will be doing so with a new leader at the helm. Peter Anastasiou,…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Cities move toward permanent outdoor dining

Read More →